Compare Fulford India with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs DR. REDDYS LAB - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA DR. REDDYS LAB FULFORD INDIA/
DR. REDDYS LAB
 
P/E (TTM) x 398.8 16.8 2,367.8% View Chart
P/BV x 6.2 3.2 192.7% View Chart
Dividend Yield % 0.1 0.7 11.6%  

Financials

 FULFORD INDIA   DR. REDDYS LAB
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
DR. REDDYS LAB
Mar-19
FULFORD INDIA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs9422,875 32.8%   
Low Rs4501,888 23.8%   
Sales per share (Unadj.) Rs691.4930.2 74.3%  
Earnings per share (Unadj.) Rs11.5117.4 9.8%  
Cash flow per share (Unadj.) Rs15.4185.8 8.3%  
Dividends per share (Unadj.) Rs2.0020.00 10.0%  
Dividend yield (eoy) %0.30.8 34.2%  
Book value per share (Unadj.) Rs380.0844.4 45.0%  
Shares outstanding (eoy) m3.90166.07 2.3%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.02.6 39.3%   
Avg P/E ratio x60.720.3 299.4%  
P/CF ratio (eoy) x45.312.8 353.5%  
Price / Book Value ratio x1.82.8 64.9%  
Dividend payout %17.417.0 102.4%   
Avg Mkt Cap Rs m2,714395,496 0.7%   
No. of employees `0000.422.0 2.0%   
Total wages/salary Rs m50533,562 1.5%   
Avg. sales/employee Rs Th6,073.07,032.8 86.4%   
Avg. wages/employee Rs Th1,137.41,527.9 74.4%   
Avg. net profit/employee Rs Th100.7887.7 11.3%   
INCOME DATA
Net Sales Rs m2,696154,482 1.7%  
Other income Rs m1253,375 3.7%   
Total revenues Rs m2,822157,857 1.8%   
Gross profit Rs m-4631,782 -0.1%  
Depreciation Rs m1511,348 0.1%   
Interest Rs m10889 1.1%   
Profit before tax Rs m5422,920 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m103,858 0.2%   
Profit after tax Rs m4519,500 0.2%  
Gross profit margin %-1.720.6 -8.4%  
Effective tax rate %17.716.8 105.0%   
Net profit margin %1.712.6 13.1%  
BALANCE SHEET DATA
Current assets Rs m1,738111,101 1.6%   
Current liabilities Rs m54558,973 0.9%   
Net working cap to sales %44.333.7 131.2%  
Current ratio x3.21.9 169.4%  
Inventory Days Days4879 61.1%  
Debtors Days Days494 4.6%  
Net fixed assets Rs m12101,245 0.0%   
Share capital Rs m39830 4.7%   
"Free" reserves Rs m1,443139,406 1.0%   
Net worth Rs m1,482140,236 1.1%   
Long term debt Rs m022,000 0.0%   
Total assets Rs m2,077224,656 0.9%  
Interest coverage x6.726.8 25.1%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.30.7 188.8%   
Return on assets %2.69.1 28.8%  
Return on equity %3.013.9 21.7%  
Return on capital %4.314.9 28.8%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m1788,673 0.0%   
Fx outflow Rs m67319,104 3.5%   
Net fx Rs m-65669,569 -0.9%   
CASH FLOW
From Operations Rs m9028,704 0.3%  
From Investments Rs m105-7,727 -1.4%  
From Financial Activity Rs m-14-21,326 0.1%  
Net Cashflow Rs m181-314 -57.5%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 5.4 70.4%  
FIIs % 0.1 35.3 0.3%  
ADR/GDR % 0.0 18.5 -  
Free float % 21.2 15.3 138.6%  
Shareholders   4,783 75,885 6.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  PFIZER  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS